Alkem Laboratories Ltd.

₹5,816.5

144 (2.5%)

ALKEM Share Price

Pharmaceuticals & Biotechnology

As on July 30, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 69,533 Cr

P/E Ratio30.21

Dividend Yield0.46 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	5,677.4	Bullish
10-DMA	5,647.2	Bullish
20-DMA	5,638.05	Bullish
50-DMA	5,485.31	Bullish
100-DMA	5,456.02	Bullish
200-DMA	5,542.66	Bullish

Historical Performance

1 Year

14.1%

3 Years

45.6%

5 Years

68.4%

10 Years

271.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	1,47,123	1,29,645	1,26,676	1,15,993	1,06,342
Total Expenditure	1,17,180	1,04,524	1,04,221	99,898	85,813
Other Income	5,943	4,937	3,108	2,161	1,626
Operating Profit	35,886	30,059	25,563	18,255	22,156
Interest	1,608	1,217	1,124	1,074	524
Depreciation	3,821	3,572	2,993	3,104	3,040
Profit Before Tax	28,709	25,270	20,231	13,048	18,443
Consolidated Net Profit	23,018	21,655	17,958	9,842	16,456
Adjusted EPS	193	181	150	82	138

Compounded Sales Growth

10 Years:24.5

5 Years:10.7

3 Years:4.9

TTM:2.6

Compounded Profit Growth

10 Years:25.4

5 Years:7.7

3 Years:18.5

TTM:1.2

Stock Price CAGR

10 Years:14

5 Years:11

3 Years:13.5

TTM:15.6

Return on Equity

10 Years:74.6

5 Years:137.7

3 Years:150.2

last year:192.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	239	239	239	239	239
Total Reserves	1,37,606	1,19,248	1,02,686	90,208	86,134
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	-780	-4,477	-6,489	-6,880	-8,927
Other Current Liabilities	11,861	10,682	8,919	8,388	7,714
Short Term Borrowings	10,852	7,349	11,726	13,071	25,706
Total Liabilities	1,90,536	1,59,528	1,40,601	1,24,542	1,27,599
Capital Work in Progress	1,379	4,766	1,484	3,103	3,395
Long Term Loans & Advances	3,636	2,780	2,037	1,391	1,544
Currents Investments	7,373	9,023	1,490	3,172	1,393
Short Term Loans and Advances	32,068	28,009	35,321	6,879	5,859
Total Current Assets	1,22,105	1,08,112	1,04,116	86,064	84,337
Total Assets	1,90,536	1,59,528	1,40,601	1,24,542	1,27,599
Adjusted Book Value	1,153	999	861	757	722

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 30.21, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 13.5%, reflecting average market performance.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹35886 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹147123 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1156109

No. of Shares: 199 (Approx)

Performance:15.6%

156109

NIFTY Performance: -1.8%

1 day Top Gainers